Patent information: Nanocoronavirus recombinant vaccine with graphene oxide as the carrier. Attached to the reporter's summary
专利资料：以氧化石墨烯为载体的纳米冠状病毒重组疫苗 。附记者综述
Patent information: Nanocoronavirus recombinant vaccine with graphene oxide as carrier （Reporter's review: In 2021, Austrian scientists discovered that there are nanoparticle toxic substances with graphene oxide as carriers in the vaccine. He described it as "like a blade" in the blood. He was arrested and murdered by police during the live broadcast. However! The new crown vaccine contains graphene oxide, which is a publicly patented technology, which can be seen from this! Without academic freedom and freedom of speech, human beings will live in blinded ignorance and ignorance and face potential life dangers! / French Free Health Human Rights Reporter: Han Rongli 记者综述：2021年，奥地利科学家发现疫苗中有氧化石墨烯为载体的纳米颗粒毒性物质，他形容在血液中“像刀片一样”，他在直播过程中被警察上门抓捕并谋杀。然而！新冠疫苗含有氧化石墨烯是一项公开的专利技术，由此可见！倘若没有学术自由与言论自由，人类会生活在被蒙蔽的无知愚昧中、面临潜在的生命危险！/ 法国自由健康人权记者：韩荣利 ）
Abstract
The present invention belongs to the field of nanomaterials and biomedicine, relates to a vaccine, and in particular, to the development of nuclear recombinant nanovaccine of the 2019-nCoV coronavirus. The invention also includes a method of preparing the vaccine and its application in animal tests. The new crown vaccine contains graphene oxide, carnosine, CpG, and new coronavirus RBD; carnosine, CpG and new coronavirus RBD are bound on the skeleton of graphene oxide; the coding sequence of the CpG is shown in SEQ ID NO 1; the new crown virus RBD refers to the new coronavirus protein receptor binding region that can produce high-valid specific antibodies against RBD in mice, providing strong support for the prevention and treatment of the new coronavirus. Images (2)
Classifications
A61K39/12 Viral antigens View 10 more classifications Landscapes
Health & Medical Sciences Life Sciences & Earth Sciences Show more CN112220919A China Download PDF Find Prior Art Similar Other languages English Inventor Cui Daxiang Gao Ang Liang Hui Tian Jing Li Xue Ling Shen Qi Current Assignee Shanghai National Engineering Research Center for Nanotechnology Co Ltd Worldwide applications 2020 CN Application CN202011031367.1A events 2020-09-27 Application filed by Shanghai National Engineering Research Center for Nanotechnology Co Ltd 2020-09-27 Priority to CN202011031367.1A 2021-01-15 Publication of CN112220919A Status Pending Info Patent citations (3) Non-patent citations (3) Cited by (1) Legal events Similar documents Priority and Related Applications External links EspacenetGlobal DossierDiscuss Description
Nanocoronavirus recombinant vaccine with graphene oxide as carrier Technical field The present invention belongs to the field of nanomaterials and biomedicine, and relates to the development of a vaccine development platform. Specifically, it involves the development of nuclear recombinant nanovaccine of 2019 -nCoV coronavirus. The invention also includes the use of the vaccine in animal testing. … …
Abstract
本发明属于纳米材料和生物医药领域，涉及一种疫苗，具体而言，涉及2019‑nCoV冠状病毒核重组纳米疫苗的开发。本发明还包括该疫苗的制备方法以及在动物试验中的应用。所述的新冠疫苗含有氧化石墨烯、肌肽、CpG、新冠病毒RBD；在氧化石墨烯的骨架上结合肌肽、CpG和新冠病毒RBD；所述的CpG的编码序列如SEQ ID NO 1所示；所述的新冠病毒RBD是指新型冠状病毒蛋白受体结合区域可以在小鼠体内产生高效价的针对RBD的特异性抗体，为新型冠状病毒的防治提供了强有力的支持。 Images (2)
Classifications
A61K39/12 Viral antigens View 10 more classifications Landscapes
Health & Medical Sciences Life Sciences & Earth Sciences Show more CN112220919A China Download PDF Find Prior Art Similar Other languages English Inventor 崔大祥高昂梁辉田静李雪玲沈琦 Current Assignee Shanghai National Engineering Research Center for Nanotechnology Co Ltd Worldwide applications 2020 CN Application CN202011031367.1A events 2020-09-27 Application filed by Shanghai National Engineering Research Center for Nanotechnology Co Ltd 2020-09-27 Priority to CN202011031367.1A 2021-01-15 Publication of CN112220919A Status Pending Info Patent citations (3) Non-patent citations (3) Cited by (1) Legal events Similar documents Priority and Related Applications External links EspacenetGlobal DossierDiscuss Description
CN112220919A - 以氧化石墨烯为载体的纳米冠状病毒重组疫苗 - Google Patents
Graphene oxide (GO, graphene oxide) is an oxide of graphene. After oxidation, the oxygen-containing functional groups on it increase, making the properties more active than graphene. For example, hydroxyl and epoxy groups are randomly distributed on graphene oxide monoliths, while carboxyl and carbonyl groups are introduced at the edges of the monoliths. Common commercially available graphene oxide products are powder, sheet and solution, with a brown-yellow color. … 氧化石墨烯（GO，graphene oxide)是石墨烯的氧化物，因经氧化后，其上含氧官能团增多而使性质较石墨烯更加活泼。例如，在氧化石墨烯单片上随机分布羟基和环氧基，而在单片的边缘则引入了羧基和羰基。常见的氧化石墨烯市售产品有粉末状、片状以及溶液状的，颜色为棕黄色。…
专利资料：以氧化石墨烯为载体的纳米冠状病毒重组疫苗 。附记者综述
Patent information:
Nanocoronavirus recombinant vaccine with graphene oxide as carrier
（Reporter's review: In 2021, Austrian scientists discovered that there are nanoparticle toxic substances with graphene oxide as carriers in the vaccine. He described it as "like a blade" in the blood. He was arrested and murdered by police during the live broadcast. However! The new crown vaccine contains graphene oxide, which is a publicly patented technology, which can be seen from this! Without academic freedom and freedom of speech, human beings will live in blinded ignorance and ignorance and face potential life dangers! / French Free Health Human Rights Reporter: Han Rongli
记者综述：2021年，奥地利科学家发现疫苗中有氧化石墨烯为载体的纳米颗粒毒性物质，他形容在血液中“像刀片一样”，他在直播过程中被警察上门抓捕并谋杀。然而！新冠疫苗含有氧化石墨烯是一项公开的专利技术，由此可见！倘若没有学术自由与言论自由，人类会生活在被蒙蔽的无知愚昧中、面临潜在的生命危险！/ 法国自由健康人权记者：韩荣利 ）
Abstract
The present invention belongs to the field of nanomaterials and biomedicine, relates to a vaccine, and in particular, to the development of nuclear recombinant nanovaccine of the 2019-nCoV coronavirus. The invention also includes a method of preparing the vaccine and its application in animal tests. The new crown vaccine contains graphene oxide, carnosine, CpG, and new coronavirus RBD; carnosine, CpG and new coronavirus RBD are bound on the skeleton of graphene oxide; the coding sequence of the CpG is shown in SEQ ID NO 1; the new crown virus RBD refers to the new coronavirus protein receptor binding region that can produce high-valid specific antibodies against RBD in mice, providing strong support for the prevention and treatment of the new coronavirus.
Images (2)
Classifications
A61K39/12 Viral antigens
View 10 more classifications
Landscapes
Health & Medical Sciences
Life Sciences & Earth Sciences
Show more
CN112220919A
China
Download PDF Find Prior Art Similar
Other languages English Inventor Cui Daxiang Gao Ang Liang Hui Tian Jing Li Xue Ling Shen Qi Current Assignee Shanghai National Engineering Research Center for Nanotechnology Co Ltd
Worldwide applications
2020 CN
Application CN202011031367.1A events
2020-09-27
Application filed by Shanghai National Engineering Research Center for Nanotechnology Co Ltd
2020-09-27
Priority to CN202011031367.1A
2021-01-15
Publication of CN112220919A
Status
Pending
Info Patent citations (3) Non-patent citations (3) Cited by (1) Legal events Similar documents Priority and Related Applications External links EspacenetGlobal DossierDiscuss
Description
Nanocoronavirus recombinant vaccine with graphene oxide as carrier
Technical field
The present invention belongs to the field of nanomaterials and biomedicine, and relates to the development of a vaccine development platform. Specifically, it involves the development of nuclear recombinant nanovaccine of 2019 -nCoV coronavirus. The invention also includes the use of the vaccine in animal testing. … …
Abstract
本发明属于纳米材料和生物医药领域，涉及一种疫苗，具体而言，涉及2019‑nCoV冠状病毒核重组纳米疫苗的开发。本发明还包括该疫苗的制备方法以及在动物试验中的应用。所述的新冠疫苗含有氧化石墨烯、肌肽、CpG、新冠病毒RBD；在氧化石墨烯的骨架上结合肌肽、CpG和新冠病毒RBD；所述的CpG的编码序列如SEQ ID NO 1所示；所述的新冠病毒RBD是指新型冠状病毒蛋白受体结合区域可以在小鼠体内产生高效价的针对RBD的特异性抗体，为新型冠状病毒的防治提供了强有力的支持。
Images (2)
Classifications
A61K39/12 Viral antigens
View 10 more classifications
Landscapes
Health & Medical Sciences
Life Sciences & Earth Sciences
Show more
CN112220919A
China
Download PDF Find Prior Art Similar
Other languages English Inventor 崔大祥高昂梁辉田静李雪玲沈琦 Current Assignee Shanghai National Engineering Research Center for Nanotechnology Co Ltd
Worldwide applications
2020 CN
Application CN202011031367.1A events
2020-09-27
Application filed by Shanghai National Engineering Research Center for Nanotechnology Co Ltd
2020-09-27
Priority to CN202011031367.1A
2021-01-15
Publication of CN112220919A
Status
Pending
Info Patent citations (3) Non-patent citations (3) Cited by (1) Legal events Similar documents Priority and Related Applications External links EspacenetGlobal DossierDiscuss
Description
CN112220919A - 以氧化石墨烯为载体的纳米冠状病毒重组疫苗 - Google Patents
以氧化石墨烯为载体的纳米冠状病毒重组疫苗
技术领域
本发明属于纳米材料和生物医药领域，涉及一种疫苗开发平台的研制。具体而言，涉及2019 -nCoV冠状病毒核重组纳米疫苗的开发。本发明还包括该疫苗在动物试验中的应用。… …
Graphene oxide (GO, graphene oxide) is an oxide of graphene. After oxidation, the oxygen-containing functional groups on it increase, making the properties more active than graphene. For example, hydroxyl and epoxy groups are randomly distributed on graphene oxide monoliths, while carboxyl and carbonyl groups are introduced at the edges of the monoliths. Common commercially available graphene oxide products are powder, sheet and solution, with a brown-yellow color. …
氧化石墨烯（GO，graphene oxide)是石墨烯的氧化物，因经氧化后，其上含氧官能团增多而使性质较石墨烯更加活泼。例如，在氧化石墨烯单片上随机分布羟基和环氧基，而在单片的边缘则引入了羧基和羰基。常见的氧化石墨烯市售产品有粉末状、片状以及溶液状的，颜色为棕黄色。…